Drugs for COVID-19
CURRENT
ISSUE
1656

The FDA has issued an Emergency Use Authorization (EUA) for an adjuvanted protein subunit COVID-19 vaccine manufactured by Novavax.1 The vaccine is indicated for use as a two-dose primary series to prevent COVID-19 in adults; it is not authorized for use in children or as a booster dose. Three other COVID-19 vaccines are available in the US for primary immunization of adults; the mRNA vaccines manufactured by Pfizer/BioNTech (Comirnaty) and Moderna (Spikevax) are FDA-licensed for this indication, and the adenovirus-based vaccine manufactured...  Continue reading

Coming Soon
Vaccines for Monkeypox
Nalmefene Returns for Reversal of Opioid Overdose
Baricitinib (Olumiant) for Alopecia Areata